Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Medicover AB (publ) Class B shares represent ownership in a Sweden-based international provider of healthcare and diagnostic services, founded in 1995. The company operates through two primary divisions: Healthcare Services, which delivers a wide spectrum of care including primary and specialist outpatient and inpatient services, hospitals, dental care, fertility treatments, and preventive wellness programs via an integrated model and fee-for-service basis; and Diagnostic Services, featuring a hub-and-spoke laboratory network offering comprehensive testing across clinical pathology specialties such as biochemistry, genetics, microbiology, and advanced diagnostics under brands like Synevo. With nearly 50,000 employees, Medicover serves over 14 million patient visits annually through an extensive network of ambulatory clinics, specialty facilities, and labs in over 20 countries, with a strong focus on Central and Eastern Europe including Poland, Romania, Germany, and Ukraine, as well as India and Nordic regions. Headquartered in Stockholm, it primarily generates revenue from Poland and caters to corporates, individuals, and public payers, emphasizing patient-centered care, digital health innovations, and accessible services in emerging and developed markets. These shares play a significant role in the healthcare providers sector, supporting growth in integrated medical facilities.